Venmax Drugs forfeits 7.8L warrants worth ₹39L

Venmax Drugs and Pharmaceuticals Ltd announced the forfeiture of 7,80,001 partly paid-up Convertible Share Warrants. These warrants, initially allotted on March 20, 2025, were forfeited due to non-payment of the balance subscription amount. The company will retain the upfront subscription amount of ₹39,00,005/- paid for these warrants. The board also approved the unaudited standalone financial results for the quarter ended June 30, 2026, along with the limited review report.